Nanotechnology approaches to eradicating HIV reservoirs.

Nanotechnology approaches to eradicating HIV reservoirs.
复制标题

DOI:
10.1016/j.ejpb.2018.06.002
复制
发表时间:
2019-05
期刊:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
影响因子:
--
通讯作者:
Woodrow KA
Woodrow KA
中科院分区:
其他
文献类型:
--
作者:
Cao S;Woodrow KA

文献摘要

参考文献

被引文献

相似文献

联合抗逆转录病毒疗法(cART)的出现已将HIV-1感染转变为一种可控的慢性疾病,但这些疗法无法根除病毒以治愈艾滋病毒。已经提出并研究了多种策略以从各种生物保护区中根除潜伏的病毒储库。然而,由于HIV感染和潜伏期维持的复杂性,单一药物不太可能消除所有HIV储库,可能需要新的策略来实现更好的疗效,同时限制全身毒性。在这篇综述中,我们描述了艾滋病毒潜伏在细胞和解剖水库,并提出了一个概述目前的策略,艾滋病毒治疗的重点是他们的挑战,临床翻译。然后,我们提供了一个纳米技术解决方案,已被用来解决艾滋病毒治疗的挑战,通过提供物理化学不同的药物组合治疗或针对艾滋病毒水库网站的摘要。我们还回顾了基于纳米载体的基因递送和免疫治疗用于癌症治疗,但可能在艾滋病毒治疗中有潜在的应用。
The advent of combination antiretroviral therapy (cART) has transformed HIV-1 infection into a controllable chronic disease, but these therapies are incapable of eradicating the virus to bring about an HIV cure. Multiple strategies have been proposed and investigated to eradicate latent viral reservoirs from various biological sanctuaries. However, due to the complexity of HIV infection and latency maintenance, a single drug is unlikely to eliminate all HIV reservoirs and novel strategies may be needed to achieve better efficacy while limiting systemic toxicity. In this review, we describe HIV latency in cellular and anatomical reservoirs, and present an overview of current strategies for HIV cure with a focus on their challenges for clinical translation. We then provide a summary of nanotechnology solutions that have been used to address challenges in HIV cure by delivering physicochemically diverse agents for combination therapy or targeting HIV reservoir sites. We also review nanocarrier-based gene delivery and immunotherapy used in cancer treatment but may have potential applications in HIV cure.
DOI: 10.1371/journal.pone.0009390
发表时间: 2010-02-23
期刊: PloS one
影响因子: 3.7
作者:
Archin NM;Cheema M;Parker D;Wiegand A;Bosch RJ;Coffin JM;Eron J;Cohen M;Margolis DM
通讯作者: Margolis DM
DOI: 10.1016/j.febslet.2011.10.018
发表时间: 2011-11-16
期刊: FEBS LETTERS
影响因子: 3.5
作者:
Bernhard, Wendy;Barreto, Kris;Sadowski, Ivan
通讯作者: Sadowski, Ivan
DOI: 10.1182/blood-2008-07-168393
发表时间: 2009-01-01
期刊: BLOOD
影响因子: 20.3
作者:
Bosque, Alberto;Planelles, Vicente
通讯作者: Planelles, Vicente
DOI: 10.1002/jbm.a.36315
发表时间: 2018-05-01
影响因子: 4.9
作者:
Cao, Shijie;Jiang, Yonghou;Woodrow, Kim A.
通讯作者: Woodrow, Kim A.
DOI: 10.1021/acs.molpharmaceut.5b00335
发表时间: 2015-12-07
影响因子: 4.9
作者:
Adesina SK;Akala EO
通讯作者: Akala EO